Treatment of systemic fungus infections.
D000666:Amphotericin B / Q000009:adverse effects / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use*; D005437:Flucytosine / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008825:Miconazole / Q000009:adverse effects / Q000627:therapeutic use; D009181:Mycoses / Q000188:drug therapy*
D000935:Antifungal Agents; D008825:Miconazole; D000666:Amphotericin B; D005437:Flucytosine